LIFE aTyr Pharma Inc.

3.85
-0.03  -1%
Previous Close 3.88
Open 3.90
Price To book 2.85
Market Cap 114387839
Shares 29,711,127
Volume 72,392
Short Ratio 7.32
Av. Daily Volume 54,268

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 updated data presented at EASL 2017.
Resolaris
Early onset facioscapulohumeral muscular dystrophy (FSHD)
Phase 1b/2 data released December 13, 2016 with further update at EASL April 2017.
Resolaris
Limb girdle muscular dystrophy (LGMD) 2B / Adult patients with facioscapulohumeral muscular dystrophy (FSHD)